Xtalks Announces Its February 2013 Life Sciences Webinar Calendar

February 7

Farewell to TQT Studies?

Speakers:
Dr. Jay Mason, Chief Medical Officer, Spaulding Clinical Research
Dr. Charles Benson, Eli Lilly and Company and E14 Implementation Working Group Member
Moderator:
Daniel Selness, Sr. VP and GM of Clinical Research, Spaulding Clinical Research

EU Good Distribution Practice Guidelines 2013

Speaker: Riekert Bruinink, Senior GMP/GDP Inspector, Dutch Health Care Inspectorate, The Netherlands

Country and Site Selection: Optimizing Protocol Planning Decisions by Leveraging Data Through Custom Algorithms

Speakers:
Chris Frega, Sr. Director and Head of Global Feasibility, Quintiles
Tom Larrichio, Senior Director, Strategic Site Intelligence, Quintiles

Developing Robust Potency Assays for Validation: A Case Study

Speaker: Peter Wunderli, Ph.D., associate director, biopharmaceutical services, PPD, cGMP laboratory

Human Research Protection and Understanding the Landscape of AAHRPP Accreditation

Speaker: Marjorie A. Speers, Ph.D., President and CEO, AAHRPP

Cutting the Cost of Clinical Research: The Solution Comes from Russia

Speakers:
Sergei Varshavsky, MD, PhD, Sr. VP, Global Strategy, Synergy Research Group
Igor Stefanov, Director, General Manager, Synergy Research Group

Item Level Serialization and Anti-counterfeiting Drug Strategies

Speakers:
Reid H. Graves, Senior Pharmaceutical Advisor, Six Degrees Counterfeit Prevention (6DCP)
Daljeet Sahni, AD EDO Engineering, Global Supply Chain, Bristol-Myers Squibb

Model-Based Drug Development (MBDD) 101: A Primer on MBDD and Its Benefits

Speakers:
N. Seth Berry, PharmD, Director, Clinical PK/PD and Modeling & Simulation, Quintiles
Russell Reeve, PhD, Senior Strategic Biostatistics Director, Quintiles